4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-16-017713
President and CEO sold 135,788 shares at an average $27.20 ($3,693,795)
- President and CEO acquired 135,788 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pomerantz Roger · President and CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-01 | Exercise or conversion : show line 1 in the form | +90,963 | $0.48 | $43,662 | 113,690 | D |
| 2016-04-01 | Sale : show line 2 in the form | −40,506 | $25.69 | $1,040,599 | 73,184 | D |
| 2016-04-01 | Sale : show line 3 in the form | −38,080 | $26.67 | $1,015,594 | 35,104 | D |
| 2016-04-01 | Sale : show line 4 in the form | −12,377 | $27.56 | $341,110 | 22,727 | D |
| 2016-04-04 | Exercise or conversion : show line 5 in the form | +44,825 | $0.48 | $21,516 | 67,552 | D |
| 2016-04-04 | Sale : show line 6 in the form | −15,203 | $28.17 | $428,269 | 52,349 | D |
| 2016-04-04 | Sale : show line 7 in the form | −22,418 | $29.18 | $654,157 | 29,931 | D |
| 2016-04-04 | Sale : show line 8 in the form | −6,416 | $29.68 | $190,427 | 23,515 | D |
| 2016-04-04 | Sale : show line 9 in the form | −788 | $30.00 | $23,640 | 22,727 | D |
| Open-market sales · 135,788 sh · avg $27.20 · $3,693,795 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-04-01 | Exercise or conversion : show line 10 in the form Stock Option (right to buy) | −90,963 | $0.48 | 2023-11-06 | 90,963 | 129,037 | D |
| 2016-04-04 | Exercise or conversion : show line 11 in the form Stock Option (right to buy) | −44,825 | $0.48 | 2023-11-06 | 44,825 | 84,212 | D |
Loading xslF345X03/doc4.xml…